U.S. market Closed. Opens in 10 hours 5 minutes

QTRX | Quanterix Corporation Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 12.80 - 13.94
52 Week Range 10.50 - 29.70
Beta 1.14
Implied Volatility 193.25%
IV Rank 57.47%
Day's Volume 394,821
Average Volume 408,909
Shares Outstanding 38,379,000
Market Cap 531,549,150
Sector Healthcare
Industry Medical - Devices
IPO Date 2017-12-07
Valuation
Profitability
Growth
Health
P/E Ratio -13.32
Forward P/E Ratio -19.41
EPS -1.04
1YR Price Target 22.50
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 441
Country USA
Website QTRX
Quanterix Corp is a life sciences company. It focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum and other fluids which are undetectable using conventional, analog immunoassay technologies. The company has developed Simoa technology which is a method of detection of proteins and has the capability of analyzing nearly six biomarkers per test, with anticipated expansion capability.
*Chart delayed
Analyzing fundamentals for QTRX we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is strong. For more detailed analysis please see QTRX Fundamentals page.

Watching at QTRX technicals we can see that long-term trend is bearish, while middle-term trend is bullish, as well as bullish short-term trend. More technicals details can be found on QTRX Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙